93 related articles for article (PubMed ID: 20484184)
21. [Management of hyperuricemia in diabetes].
Hirai A; Saito Y
Nihon Rinsho; 1997 Nov; 55 Suppl():781-5. PubMed ID: 9434564
[No Abstract] [Full Text] [Related]
22. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
Arntz HR; Dreykluft HR; Leonhardt H
Fortschr Med; 1979 Jul; 97(27):1212-4. PubMed ID: 457017
[TBL] [Abstract][Full Text] [Related]
23. [Hyperuricemia and gout--treatment].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
[No Abstract] [Full Text] [Related]
24. Fulminant hepatic failure associated with benzbromarone treatment: a case report.
Arai M; Yokosuka O; Fujiwara K; Kojima H; Kanda T; Hirasawa H; Saisho H
J Gastroenterol Hepatol; 2002 May; 17(5):625-6. PubMed ID: 12084041
[No Abstract] [Full Text] [Related]
25. [Essential hypertension].
Murakami H; Shimamoto K
Nihon Rinsho; 2003 Jan; 61 Suppl 1():235-40. PubMed ID: 12629724
[No Abstract] [Full Text] [Related]
26. [Gout].
Gröbner W; Zöllner N
Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273
[TBL] [Abstract][Full Text] [Related]
27. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
Kamilli I; Gresser U; Pellkofer T; Löffler W; Zöllner N
Z Rheumatol; 1989; 48(6):307-12. PubMed ID: 2623976
[TBL] [Abstract][Full Text] [Related]
28. Approach to the treatment of hyperuricemia.
Poon SH; Hall HA; Zimmermann B
Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894
[No Abstract] [Full Text] [Related]
29. [Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
Hisatome I; Ogino K; Igawa O; Shigemasa C
Nihon Rinsho; 2003 Jan; 61 Suppl 1():403-9. PubMed ID: 12629757
[No Abstract] [Full Text] [Related]
30. Status of uric acid management in hypertensive subjects.
Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
[TBL] [Abstract][Full Text] [Related]
31. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
Matzkies F; Neuwirth R; Berg G
Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
[TBL] [Abstract][Full Text] [Related]
32. [The effect of benzbromaron in gout patients with limited kidney function].
Kuzmits R; Bresnik W; Müller MM
Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
[TBL] [Abstract][Full Text] [Related]
33. Benzbromarone withdrawn from the European market: another case of "absence of evidence is evidence of absence"?
Jansen TL; Reinders MK; van Roon EN; Brouwers JR
Clin Exp Rheumatol; 2004; 22(5):651. PubMed ID: 15485024
[No Abstract] [Full Text] [Related]
34. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R
Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688
[TBL] [Abstract][Full Text] [Related]
35. [Gout: physiopathology, diagnosis, course, treatment].
Chazerain P; Ziza JM
Rev Prat; 1998 Sep; 48(13):1453-6. PubMed ID: 10050628
[No Abstract] [Full Text] [Related]
36. Fatal fulminant hepatic failure associated with benzbromarone.
Wagayama H; Shiraki K; Sugimoto K; Fujikawa K; Shimizu A; Takase K; Nakano T; Tameda Y
J Hepatol; 2000 May; 32(5):874. PubMed ID: 10845680
[No Abstract] [Full Text] [Related]
37. Gout--is Lee's 2008 risk:benefit conclusion for benzbromarone hepatotoxicity still relevant today?
Gravatt L
N Z Med J; 2013 Sep; 126(1382):118-9. PubMed ID: 24154779
[No Abstract] [Full Text] [Related]
38. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
[TBL] [Abstract][Full Text] [Related]
39. The pharmacology of hypouricemic effect of benzbromarone.
Sinclair DS; Fox IH
J Rheumatol; 1975 Dec; 2(4):437-45. PubMed ID: 1206675
[TBL] [Abstract][Full Text] [Related]
40. [Gout and hyperuricaemia--should both be treated?].
Uhlig T
Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2878-80. PubMed ID: 14600714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
